[Effect of zinc deficiency on effectiveness of the treatment of liver encephalopathy in patients with liver cirrhoses].

PubWeight™: 0.75‹?›

🔗 View Article (PMID 18389597)

Published in Eksp Klin Gastroenterol on January 01, 2007

Authors

N A Shaposhnikova, V N Drozdov, A V Petrakov, S Iu Sil'vestrova

Articles by these authors

[Realities and prospects for the use of cell technologies for the treatment of chronic diffuse liver diseases]. Eksp Klin Gastroenterol (2011) 0.80

[The treatment of primary biliary liver cirrhosis with rifampicin]. Ter Arkh (1993) 0.79

[Antiproliferative activity of diclofenac at tumor cell cultures]. Eksp Klin Gastroenterol (2012) 0.79

[Role of stress in the etiopathogenesis of duodenal ulcer in young patients]. Eksp Klin Gastroenterol (2002) 0.77

[Level of blood uric acid in patients with postinfarction heart failure]. Ter Arkh (2000) 0.77

[The damaging role of endogenous nitric oxide in the development of the experimental DSS-induced colitis in rats]. Eksp Klin Gastroenterol (2010) 0.76

[Bone mineral density in patients with gluten-sensitivity celiac disease]. Ter Arkh (2010) 0.76

Investigation of cholesterol, bilirubin, and protein distribution in human gallstones by color cathodoluminescence scanning electron microscopy and transmission electron microscopy. Scanning (1998) 0.76

[Pharmacokinetic and pharmacodynamic characteristics of antihypertensive drugs in the treatment of hypertensive patients with chronic diseases of the liver]. Ter Arkh (2011) 0.76

[Efficiency of famotidin in prophylaxis of NSAIDs-induced gastropathy: result of multicenter research ZASLON-1 (protection of gastric mucosa from non-steroidal anti-inflammatory drugs]. Eksp Klin Gastroenterol (2009) 0.75

[Polymorphism of GPIIIA platelet glycoprotein gene PIA1/A2 compared to plasma hemostasis in myocardial infarction patients]. Ter Arkh (1999) 0.75

[Nitric oxide and indicators of oxidative stress in patients with exacerbation of chronic pancreatitis]. Eksp Klin Gastroenterol (2011) 0.75

[Role of cholestasis in development of copper metabolism disorder in patients with chronic liver disease]. Eksp Klin Gastroenterol (2009) 0.75

[Bone mineral density infringement in patients with digestive system diseases]. Eksp Klin Gastroenterol (2011) 0.75

[Modern approach to the prevention and treatment of NSAID-gastropathy]. Eksp Klin Gastroenterol (2011) 0.75

[Monooxigenase activity in liver diseases (study based on data of antipyrine metabolism)]. Ter Arkh (1987) 0.75

[Prevalence and clinical-morphological characteristics of anemia in patients with chronic liver diseases]. Eksp Klin Gastroenterol (2010) 0.75

[The role of E2 and F2alpha prostaglandins in development of erosive-ulcerative lesions of the gastroduodenal region]. Eksp Klin Gastroenterol (2009) 0.75

[Characteristics of the intestinal dysbiosis and endotoxemia after hemicolectomy]. Eksp Klin Gastroenterol (2011) 0.75

[Efficacy of lisinopril and nebivolol therapy of portal hypertension and kidney dysfunction in patients with liver cirrhosis]. Eksp Klin Gastroenterol (2008) 0.75

[Bone mineral density in patients with celiac disease and medical treatment of the disorder]. Eksp Klin Gastroenterol (2011) 0.75

[Peculiarities of diabetes mellitus course in chronic pancreatitis]. Eksp Klin Gastroenterol (2011) 0.75

[Exocrine function of the pancreas at chronic pancreatitis: diagnosis an drug correction]. Eksp Klin Gastroenterol (2009) 0.75

[Diagnosis of spontaneous bacterial peritonitis in liver cirrhosis]. Eksp Klin Gastroenterol (2008) 0.75

[Protein that binds fatty acids (I-FABP)--a new perspective evidence for injury of the small intestine]. Eksp Klin Gastroenterol (2011) 0.75

[Antipyrine metabolism and rat liver ultrastructure in single and combined action of trichlorodiphenyl and dioctyl phthalate]. Biull Eksp Biol Med (1992) 0.75

[Endoscopic retrograde cholangiopancreatography: standards of the procedure]. Eksp Klin Gastroenterol (2009) 0.75

[Pharmacokinetics of enalapril and metoprolol in hypertensive patients with hepatic pathology]. Ter Arkh (2007) 0.75

[Gilbert's syndrome: a clinicogenetic trial]. Ter Arkh (2006) 0.75

[Experimental NSAID-associated gastric mucosa injuries]. Eksp Klin Gastroenterol (2008) 0.75

[Bone mineral density in patients with liver cirrhosis]. Eksp Klin Gastroenterol (2009) 0.75

[Clinical and diagnostic significance of gepsidin level in the regulation of iron metabolism in patients with inflammatory bowel disease]. Eksp Klin Gastroenterol (2011) 0.75

[Experimental study of NSAID effect on prostaglandine contents]. Eksp Klin Gastroenterol (2007) 0.75

[Celecoxib and Tramadol as an alternative osteoarthrosis therapy in patients with NSAID gastropathy]. Eksp Klin Gastroenterol (2004) 0.75

[Functional renal reserve of patients with liver cirrhoses]. Eksp Klin Gastroenterol (2007) 0.75

[New possibilities for overcoming the secondary inefficiency of anti-cytokine therapy in patients with inflammatory bowel diseases]. Ter Arkh (2013) 0.75

[Oncogenesis humoral mechanisms regulation and NSAIDs ability in prevention of tumors]. Eksp Klin Gastroenterol (2011) 0.75

[Combination therapy of arterial hypertension combined with liver pathology. The place of angiotensin converting enzyme inhibitors]. Kardiologiia (2009) 0.75

[Cytomegalovirus infection in patients with ulcerative colitis]. Eksp Klin Gastroenterol (2010) 0.75

[The frequency of anemia among patients of gastroenterological hospital]. Eksp Klin Gastroenterol (2011) 0.75

[Modeling damage of the mucous membrane of the gastrointestinal tract in rats]. Eksp Klin Gastroenterol (2011) 0.75

[Nonalcoholic fatty liver disease and insulin resistance: clinical, biochemical, and morphological parallels]. Eksp Klin Gastroenterol (2008) 0.75

[Disorder of mineral density of the bone tissue in patients with chronic pancreatitis]. Eksp Klin Gastroenterol (2008) 0.75

[Causes of biliary sludge]. Ter Arkh (2003) 0.75

[Fosinorm in the treatment of essential hypertension with a metabolic syndrome]. Ter Arkh (1997) 0.75

[Disorders of bone mineral density in patients with cholelithiasis and postcholecystectomic syndrome]. Eksp Klin Gastroenterol (2010) 0.75

[Changes in concentration of cholecystokinin-pancreozymin in patients with cholelithiasis before and after cholecystectomy]. Eksp Klin Gastroenterol (2010) 0.75

[Quality of life of patients with hyperendotoxemia after hemicolectomy]. Eksp Klin Gastroenterol (2011) 0.75

[Change of nitric oxide metabolites in patients with chronic pancreatitis]. Eksp Klin Gastroenterol (2008) 0.75

[Risk of development of clinical and pathogenetic features of anemia on the background of basic therapy of inflammatory bowel disease]. Eksp Klin Gastroenterol (2011) 0.75

[Diagnostic potential of a new functional test used in intestinal diseases--determination of hydrogen in exhaled air]. Ter Arkh (1991) 0.75

[Efficacy of chondroitin sulphate in the treatment of elderly patients with gonarthrosis and coxarthrosis]. Ter Arkh (2005) 0.75

[Lipid peroxidation markers in the exhaled breath and microsomal oxidation in patients with chronic diffuse liver diseases]. Ter Arkh (1995) 0.75

[Features of bone metabolism in patients with chronic diseases of digestive system]. Eksp Klin Gastroenterol (2011) 0.75

[The function of the small intestine based on hydrogen test data in men who have been exposed to small doses of ionizing radiation in the cleanup of the sequelae of the accident at the Chernobyl Atomic Electric Power Station]. Ter Arkh (1992) 0.75

[Detoxifying function of the liver in patients with rubromycosis during treatment with antimycotics]. Vestn Dermatol Venerol (1989) 0.75

[The role of the population risk factors in the genesis of osteo metabolism in patients with chronic diseases of the digestive system]. Eksp Klin Gastroenterol (2011) 0.75

[VITAMIN D DEFICIENCY AS A FACTOR POLYMORBIDITY]. Eksp Klin Gastroenterol (2015) 0.75

[Diagnostic value of interleukin-6 level during the post-operative period]. Klin Lab Diagn (1999) 0.75

[Laboratory diagnostics of acute pancreatitis]. Eksp Klin Gastroenterol (2003) 0.75

[Variations and frequency of distribution of quantitative value of acetylcholine and cholinesterase activity in blood serum of healthy persons]. Eksp Klin Gastroenterol (2007) 0.75

[Fecal excretion of short-chain fatty acids as a marker of the severity of ulcerative colitis]. Ter Arkh (2010) 0.75

[Spontaneous bacterial peritonitis: scientific and practical achievements and prospects]. Eksp Klin Gastroenterol (2011) 0.75

[The clinical significance of hereditary and acquired alpha-1-antitrypsin deficiency in patients with liver cirrhosis and Wilson-Konovalov disease]. Eksp Klin Gastroenterol (2010) 0.75

[ACE inhibitors in the treatment of patients with arterial hypertension and pathology of the digestive system]. Eksp Klin Gastroenterol (2007) 0.75

[Role of exocrine pancreatic insufficiency in reducing of the bone mineral density in patients with chronic pancreatitis]. Eksp Klin Gastroenterol (2010) 0.75

[Effect of enzyme supportive therapy of the Ermital' on a quality of life of patients with chronic pancreatitis]. Eksp Klin Gastroenterol (2010) 0.75

[Deficiency of essential microelements in patients with diseases of the digestive system]. Eksp Klin Gastroenterol (2011) 0.75

[Plasma hemostasis and biochemical indices in trimetazidine treatment of patients with chronic heart failure]. Ter Arkh (1998) 0.75

[Nitric oxide as an inflammation marker at non-specific ulcerous colitis and Crohn's disease]. Eksp Klin Gastroenterol (2006) 0.75

[Violations of colon microbiocenosis and lipid metabolism after hemicolectomy]. Eksp Klin Gastroenterol (2010) 0.75

[Non-steroidal anti-inflammatory drugs and tramadol in the treatment of osteoarthrosis deformans in patients with arterial hypertension]. Klin Med (Mosk) (2004) 0.75

[The angiotensin-converting enzyme inhibitor perindopril in the treatment of congestive heart failure]. Ter Arkh (1997) 0.75

[Antipyrine test in evaluating the detoxifying function of the liver in chronic diseases]. Ter Arkh (1982) 0.75

[Protective hepatotropic effect of preparations from mussels and ginseng during exposure of animals to dioctylphthalate]. Biull Eksp Biol Med (1994) 0.75

[Interconnection in activity of lipid peroxidation reactions and functional status of the liver in patients with chronic hepatitis of viral etiology]. Eksp Klin Gastroenterol (2002) 0.75

[The specific features of pancreatic incretory dysfunction in chronic pancreatitis]. Ter Arkh (2012) 0.75

[Hydrogen test: its diagnostic possibilities in intestinal diseases]. Klin Med (Mosk) (1990) 0.75

[Vitamin D exchange and its active metabolite at celiac disease]. Eksp Klin Gastroenterol (2010) 0.75

[Pharmacokinetics of iron medication and efficacy of therapy with oral iron supplementation]. Eksp Klin Gastroenterol (2011) 0.75

[Pharmacokinetics of preparations of lipoic acid and their effect on ATP synthesis, processes of microsomal and cytosol oxidation in hepatocytes in liver damage in man]. Farmakol Toksikol (1989) 0.75

[Role of nitric oxide (NO) in the etiopathogenesis of certain alimentary diseases]. Eksp Klin Gastroenterol (2005) 0.75

[Syndrome of iron overload and its impact on the clinical course and risk of complications in patients with liver cirrhosis]. Eksp Klin Gastroenterol (2011) 0.75

[Atenolol and metoprolol differentiated therapy of patients with arterial hypertension complicated by pathology of the digestive tract organs]. Eksp Klin Gastroenterol (2008) 0.75

[Spontaneous bacterial peritonitis and systemic inflammatory reaction in hepatic cirrhosis patients]. Ter Arkh (2011) 0.75

[Disorder of bone mineral density in patients with the digestive system diseases]. Eksp Klin Gastroenterol (2011) 0.75

[Effect of ursodeoxycholic acid for reducing the deficit of vitamin D status and bone mineral density at gallstones]. Eksp Klin Gastroenterol (2010) 0.75

[Preparations of alpha-lipoic acid: the dynamics of their content in the blood and their effect on hemostasis in lesions of the human liver]. Farmakol Toksikol (1990) 0.75

[Effect of hepatitis C virus genotype on viral load and clinical-laboratory characteristics of liver disease]. Eksp Klin Gastroenterol (2010) 0.75

[New approaches to diagnostics of spontaneous bacterial peritonitis in liver cirrhosis]. Eksp Klin Gastroenterol (2008) 0.75

[Spontaneous bacterial peritonitis in liver cirrhosis: optimization issues of prevention and treatment]. Eksp Klin Gastroenterol (2012) 0.75

[Complex interpretation of aggregatograms for assessing the functional activity of platelets in patients with hypertension]. Klin Lab Diagn (1999) 0.75

[Replicative activity of hepatitis B as a factor determining the progression of liver fibrosis and cirrhosis]. Eksp Klin Gastroenterol (2011) 0.75

[Diagnostic value of serum markers of fibrosis in chronic liver diseases]. Ter Arkh (2013) 0.75

[Etiology and pathogenesis of duodenal mucosa lesion in chronic pancreatitis]. Ter Arkh (2009) 0.75

[Violation of bone mineral density tissue and its correction in patients with celiac disease]. Eksp Klin Gastroenterol (2011) 0.75

[Computer system for image analysis of fluorescently stained bacteria]. Mikrobiologiia (2007) 0.75